Last updated on December 2019

A PHASE 2B PLACEBO-CONTROLLED RANDOMIZED STUDY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE IN PREGNANT WOMEN


Brief description of study

This Phase 2b study will evaluate the safety, tolerability, and immunogenicity of an RSV vaccine in pregnant participants who receive either one of 2 dose levels of the vaccine, formulated with or without aluminum hydroxide, or placebo, and investigate safety and characteristics of antibodies in their infants.

Detailed Study Description

This Phase 2b, multicenter, randomized, placebo-controlled study will evaluate the safety, tolerability, and immunogenicity of a respiratory syncytial virus stabilized prefusion F subunit vaccine (RSV vaccine) in pregnant participants who receive either one of 2 dose levels of the vaccine, formulated with or without aluminum hydroxide, or placebo, as well as assess safety and characteristics of transplacentally transferred antibodies in their infants.

Clinical Study Identifier: NCT04032093

Find a site near you

Start Over

Intermountain Medical Center

Murray, UT United States
6.28miles
  Connect »

JBR Clinical Research

Salt Lake City, UT United States
6.28miles
  Connect »

Old Farm Obstetrics & Gynecology, LLC

Salt Lake City, UT United States
6.28miles
  Connect »

Old Farm Obstetrics & Gynecology

Salt Lake City, UT United States
6.33miles
  Connect »

St. Marks Hospital

Salt Lake City, UT United States
9.89miles
  Connect »